Collaboration - February 19, 2020
AstraZeneca and IBM collaborate in order to strengthen digital health expertise
AstraZeneca’s BioVentureHub has entered into a new collaboration with IBM Sweden. The collaboration gives small and mid-sized companies connected to IBM Sweden or AstraZeneca’s BioVentureHub access to each others’ open platforms for innovation. The collaboration aims to stimulate growth of small and mid-sized companies, to support knowledge exchange between life sciences and digital technology, and […]
Financing - February 19, 2020
15 million SEK invested in MediTuner
15 million SEK has been invested in MediTuners’s digital asthma-app. Almi Invest is investing 3 million SEK in MediTuner and its app AsthmaTuner, developed together with Karolinska Institutet. The app is connected to a spirometry and provides asthma patients with an automatic treatment recommendation. In this emission consisting of 15 million SEK a number of […]
Career choice - January 19, 2020
Digital health entrepreneurs
As Swedish clinicians treating large numbers of asthma patients, Henrik Ljungberg and Björn Nordlund often spent time reviewing the multiple prescriptions and directives patients received from different providers after flare-ups.
Agreement - January 16, 2020
Microsoft and MSD in strategic partnership for Nordic and Baltic life science
The two companies have agreed on a partnership for the Nordic and Baltic markets with the aim to support healthcare. One possible field of cooperation is the use of cutting-edge technique, such as artificial intelligence, to support early diagnosis for i.a. lung cancer, they state. “The Nordic and Baltic states are at the forefront of […]
Agreement - January 13, 2020
Coala-Life and Asahi Kasei enter technology partnership in Japan
Coala Life has announced a research and development partnership with Asahi Kasei Corporation in Japan. The collaboration includes a development program and research targeting Heart Failure (HF) patients in Japan. Exclusively on the Japanese market Coala Life has partnered with Asahi Kasei Corporation exclusively on the Japanese market to further develop and evaluate the use of […]
Agreement - November 28, 2019
Orexo acquires US rights to commercialize vorvida
Orexo has acquired the exclusive US rights to vorvida, a digital therapy for the treatment of Alcohol Use Disorder (AUD), from GAIA. This news follows an earlier agreement with GAIA in August 2019, for the exclusive global commercial rights to OXD01, a new digital therapy being developed for the treatment of Opioid Use Disorder (OUD). […]
